Eric Mou

18PUBLICATIONS

147CO-AUTHORS

Disease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsies

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Jun 24, 2026

No association of prior administration of selected vaccines with lymphoma prognosis.

|Apr 25, 2026

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.

|Apr 14, 2026

Diagnosis-to-treatment interval is associated with outcomes in follicular lymphoma treated with immunochemotherapy.

Prokop Vodička, Tarec C El-Galaly, Vit Prochazka

|Feb 24, 2026

Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.

Yucai Wang, Melissa C Larson, Steven R Hwang

|Feb 18, 2026

Patterns of care and clinical outcomes in systemic peripheral T-cell lymphoma: the LEO-MER prospective cohort study.

Jia Ruan, Zhengming Chen, Melissa C Larson

|Dec 11, 2025

Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.

Yucai Wang, Melissa C Larson, Steven R Hwang

Pageof 3

Frequent Collaborators

12 joint publications

Matthew Maurer

James R Cerhan

Yucai Wang

Brad S Kahl

Jordan Carter

Andrew L Feldman

Izidore S Lossos

Reem Karmali

Steven R Hwang

Natalie S Grover

Frequent Collaborators

12 joint publications

Matthew Maurer

9 joint publications

James R Cerhan

7 joint publications

Yucai Wang

7 joint publications

Brad S Kahl